Understanding Intracellular Signaling Advances Cardiac Reprogramming Technology Toward Clinical Applications

被引:0
作者
Yoshida, Yoshinori [1 ]
Yamanaka, Shinya [1 ,2 ]
机构
[1] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan
[2] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA
关键词
IN-VITRO; FIBROBLASTS; AKT; ACTIVATION; GROWTH; CARDIOMYOCYTES; EXPRESSION; INDUCTION; INJURY; CELLS;
D O I
10.1161/CIRCRESAHA.115.308075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The direct reprogramming of fibroblasts into functional cardiac myocytes is expected to bring new cell therapies for heart failure. Already, essential transcription factors for the reprogramming have been identified. However, several obstacles must be overcome before this technology benefits patients. In particular, there is a need to improve the efficiency of the reprogramming, especially with regards to acquiring mature cardiomyocytes. A recent article in Proceedings of the National Academy of Sciences suggests that the reprogramming can be enhanced with the addition of a kinase, Akt, to the induction protocol. ©2016 American Heart Association, Inc.
引用
收藏
页码:377 / 378
页数:2
相关论文
共 23 条
[1]   Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart [J].
Fujio, Y ;
Nguyen, T ;
Wencker, D ;
Kitsis, RN ;
Walsh, K .
CIRCULATION, 2000, 101 (06) :660-667
[2]   Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors [J].
Ieda, Masaki ;
Fu, Ji-Dong ;
Delgado-Olguin, Paul ;
Vedantham, Vasanth ;
Hayashi, Yohei ;
Bruneau, Benoit G. ;
Srivastava, Deepak .
CELL, 2010, 142 (03) :375-386
[3]   Inhibition of TGFβ Signaling Increases Direct Conversion of Fibroblasts to Induced Cardiomyocytes [J].
Ifkovits, Jamie L. ;
Addis, Russell C. ;
Epstein, Jonathan A. ;
Gearhart, John D. .
PLOS ONE, 2014, 9 (02)
[4]   Induction of Cardiomyocyte-Like Cells in Infarct Hearts by Gene Transfer of Gata4, Mef2c, and Tbx5 [J].
Inagawa, Kohei ;
Miyamoto, Kazutaka ;
Yamakawa, Hiroyuki ;
Muraoka, Naoto ;
Sadahiro, Taketaro ;
Umei, Tomohiko ;
Wada, Rie ;
Katsumata, Yoshinori ;
Kaneda, Ruri ;
Nakade, Koji ;
Kurihara, Chitose ;
Obata, Yuichi ;
Miyake, Koichi ;
Fukuda, Keiichi ;
Ieda, Masaki .
CIRCULATION RESEARCH, 2012, 111 (09) :1147-1156
[5]   MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes [J].
Jayawardena, Tilanthi M. ;
Egemnazarov, Bakytbek ;
Finch, Elizabeth A. ;
Zhang, Lunan ;
Payne, J. Alan ;
Pandya, Kumar ;
Zhang, Zhiping ;
Rosenberg, Paul ;
Mirotsou, Maria ;
Dzau, Victor J. .
CIRCULATION RESEARCH, 2012, 110 (11) :1465-+
[6]   Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy [J].
Kemi, Ole Johan ;
Ceci, Marcello ;
Wisloff, Ulrik ;
Grimaldi, Serena ;
Gallo, Paolo ;
Smith, Godfrey L. ;
Condorelli, Gianluigi ;
Ellingsen, Oyvind .
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 214 (02) :316-321
[7]  
Matsui T, 2001, CIRCULATION, V104, P330
[8]   Akt and PI 3-Kinase Signaling in Cardiomyocyte Hypertrophy and Survival [J].
Matsui, Takashi ;
Nagoshi, Tomohisa ;
Rosenzweig, Anthony .
CELL CYCLE, 2003, 2 (03) :220-223
[9]   MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures [J].
Muraoka, Naoto ;
Yamakawa, Hiroyuki ;
Miyamoto, Kazutaka ;
Sadahiro, Taketaro ;
Umei, Tomohiko ;
Isomi, Mari ;
Nakashima, Hanae ;
Akiyama, Mizuha ;
Wada, Rie ;
Inagawa, Kohei ;
Nishiyama, Takahiko ;
Kaneda, Ruri ;
Fukuda, Toru ;
Takeda, Shu ;
Tohyama, Shugo ;
Hashimoto, Hisayuki ;
Kawamura, Yoshifumi ;
Goshima, Naoki ;
Aeba, Ryo ;
Yamagishi, Hiroyuki ;
Fukuda, Keiichi ;
Ieda, Masaki .
EMBO JOURNAL, 2014, 33 (14) :1565-1581
[10]   Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002 [J].
Naito, AT ;
Tominaga, A ;
Oyamada, M ;
Oyamada, Y ;
Shiraishi, I ;
Monzen, K ;
Komuro, I ;
Takamatsu, T .
EXPERIMENTAL CELL RESEARCH, 2003, 291 (01) :56-69